Brought to you by 
Ontogeny completes second IPO-sized venture round
13 Jul 1999
Executive Summary
Ontogeny (therapeutics based on developmental biology) raised over $28mm in a private placement, led by Vulcan Ventures, to existing and new investors. It plans to accelerate R&D programs, in-license complementary technologies, and expand facilities.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ontogeny completes second IPO-sized venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice